Difference between revisions of "Part:BBa K5082016"
Line 2: | Line 2: | ||
<partinfo>BBa_K5082016 short</partinfo> | <partinfo>BBa_K5082016 short</partinfo> | ||
− | miR-22-sponge-improvement | + | ===miR-22-sponge-improvement=== |
===Usage and Biology=== | ===Usage and Biology=== |
Revision as of 10:59, 30 September 2024
pre-miR-22
miR-22-sponge-improvement
Usage and Biology
From 2023 YiYe-China’s results, we found that the miR-22 sensor worked more accurately and efficiently than miR-145. Therefore, we decided to design our improved experiment based on the miR-22 sensor(BBa_K4789002).
This year, we redesigned the miR-22-sponge-pepper part by adding three additional miR-22 binding sites with 3-nt spacers for bulged sites based on the sequence of hsa-miR-22 according to a previous study [6]. Therefore, the new sensor will be more sensitive to the miR-22 concentration in cells. The part is called Improved miR-22-sponge-pepper (BBa_K5082017) and its sequence is shown in Figure 1.
Figure 1. Part improved miR-22-sponge-pepper.
References
[1] YiYe-China. “Home | YiYe-China - IGEM 2023.” iGEM.wiki, 2023, 2023.igem.wiki/yiye-china/. Accessed 7 Aug. 2024.
[2] ---. “Cervical Cancer.” World Health Organization, 2019, www.who.int/health-topics/cervical-cancer#tab=tab_1. Accessed 8 Aug. 2024.
[3] JIANG, YAN, et al. “The Role of MALAT1 Correlates with HPV in Cervical Cancer.” Oncology Letters, vol. 7, no. 6, 24 Mar. 2014, pp. 2135–2141, https://doi.org/10.3892/ol.2014.1996. Accessed 9 Aug. 2024.
[4] Kazem Nejati, et al. “MicroRNA-22 in Female Malignancies: Focusing on Breast, Cervical, and Ovarian Cancers.” Pathology - Research and Practice, vol. 223, 1 July 2021, pp. 153452–153452, https://doi.org/10.1016/j.prp.2021.153452. Accessed 9 Aug. 2024.
[5] Sawant, Dwitiya, and Brenda Lilly. “MicroRNA-145 Targets in Cancer and the Cardiovascular System: Evidence for Common Signaling Pathways.” Vascular Biology, 23 Oct. 2020, https://doi.org/10.1530/vb-20-0012. Accessed 9 Aug. 2024.
[6] Ebert, Margaret S et al. “MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.” Nature methods vol. 4,9 (2007): 721-6. doi:10.1038/nmeth1079. Accessed 9 Aug. 2024.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 147
- 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 147
- 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 147
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 147
- 1000COMPATIBLE WITH RFC[1000]